Business Description
Rhythm Biosciences Ltd
ISIN : AU000000RHY2
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.63 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 5.2 | |||||
3-Year EPS without NRI Growth Rate | 21.4 | |||||
3-Year FCF Growth Rate | 2.4 | |||||
3-Year Book Growth Rate | -27.9 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 27.58 | |||||
9-Day RSI | 35.75 | |||||
14-Day RSI | 41.3 | |||||
6-1 Month Momentum % | 41.98 | |||||
12-1 Month Momentum % | -40.4 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.58 | |||||
Quick Ratio | 1.58 | |||||
Cash Ratio | 1.34 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.3 | |||||
Shareholder Yield % | -11.22 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -257.62 | |||||
ROA % | -184.33 | |||||
ROIC % | -489.82 | |||||
ROC (Joel Greenblatt) % | -1111.3 | |||||
ROCE % | -252.23 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 30.67 | |||||
EV-to-EBIT | -3.72 | |||||
EV-to-EBITDA | -3.83 | |||||
EV-to-FCF | -4.1 | |||||
Earnings Yield (Greenblatt) % | -26.88 | |||||
FCF Yield % | -23.84 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Rhythm Biosciences Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.018 | ||
Beta | 0 | ||
Volatility % | 74.41 | ||
14-Day RSI | 41.3 | ||
14-Day ATR (€) | 0.003741 | ||
20-Day SMA (€) | 0.06565 | ||
12-1 Month Momentum % | -40.4 | ||
52-Week Range (€) | 0.027 - 0.109039 | ||
Shares Outstanding (Mil) | 283.6 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Rhythm Biosciences Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Rhythm Biosciences Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Rhythm Biosciences Ltd Frequently Asked Questions
What is Rhythm Biosciences Ltd(FRA:0RY)'s stock price today?
When is next earnings date of Rhythm Biosciences Ltd(FRA:0RY)?
Does Rhythm Biosciences Ltd(FRA:0RY) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |